Anna Margaret Schmoker, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-fyn | 3 | 2020 | 116 | 1.520 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2020 | 146 | 0.700 |
Why?
|
| Membrane Proteins | 4 | 2020 | 7880 | 0.670 |
Why?
|
| Oncogene Proteins v-abl | 1 | 2017 | 22 | 0.630 |
Why?
|
| Triatoma | 3 | 2022 | 13 | 0.550 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 1423 | 0.460 |
Why?
|
| Insect Vectors | 3 | 2022 | 134 | 0.390 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 2916 | 0.370 |
Why?
|
| Chagas Disease | 3 | 2022 | 166 | 0.370 |
Why?
|
| Neoplasm Proteins | 2 | 2020 | 3703 | 0.350 |
Why?
|
| Blood Platelets | 1 | 2020 | 2508 | 0.330 |
Why?
|
| Proteomics | 2 | 2019 | 3638 | 0.330 |
Why?
|
| Phosphorylation | 6 | 2021 | 8436 | 0.290 |
Why?
|
| Hemoglobins | 2 | 2022 | 1534 | 0.240 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2022 | 361 | 0.230 |
Why?
|
| Factor V | 1 | 2024 | 178 | 0.230 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4204 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5853 | 0.220 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2023 | 2043 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2021 | 23403 | 0.180 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2021 | 261 | 0.180 |
Why?
|
| Amino Acid Sequence | 4 | 2020 | 13815 | 0.180 |
Why?
|
| Blood Chemical Analysis | 1 | 2022 | 440 | 0.180 |
Why?
|
| Animal Feed | 1 | 2019 | 110 | 0.170 |
Why?
|
| Phosphopeptides | 1 | 2020 | 241 | 0.170 |
Why?
|
| Blood Group Antigens | 1 | 2020 | 180 | 0.160 |
Why?
|
| src Homology Domains | 1 | 2018 | 364 | 0.150 |
Why?
|
| Trypanosoma cruzi | 1 | 2019 | 198 | 0.150 |
Why?
|
| Cysteine | 2 | 2020 | 874 | 0.150 |
Why?
|
| Cyclic GMP | 1 | 2018 | 409 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5535 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2022 | 5172 | 0.140 |
Why?
|
| Platelet Aggregation | 1 | 2020 | 798 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2017 | 2839 | 0.140 |
Why?
|
| Fibrinogen | 1 | 2020 | 894 | 0.140 |
Why?
|
| Drug Design | 1 | 2021 | 1076 | 0.140 |
Why?
|
| Platelet Activation | 1 | 2020 | 673 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1692 | 0.130 |
Why?
|
| Protein Binding | 2 | 2018 | 9386 | 0.130 |
Why?
|
| Albumins | 1 | 2018 | 569 | 0.130 |
Why?
|
| Imidazoles | 1 | 2021 | 1206 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2017 | 474 | 0.130 |
Why?
|
| Neoplasms | 2 | 2024 | 21683 | 0.120 |
Why?
|
| Conserved Sequence | 1 | 2017 | 1202 | 0.120 |
Why?
|
| Eye | 1 | 2017 | 729 | 0.110 |
Why?
|
| Tyrosine | 1 | 2017 | 1461 | 0.110 |
Why?
|
| Epitopes | 1 | 2020 | 2571 | 0.110 |
Why?
|
| Sequence Alignment | 1 | 2017 | 2256 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1730 | 0.110 |
Why?
|
| Plasmids | 1 | 2017 | 2307 | 0.110 |
Why?
|
| Binding Sites | 2 | 2017 | 6114 | 0.100 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 4320 | 0.100 |
Why?
|
| Feeding Behavior | 2 | 2022 | 3188 | 0.090 |
Why?
|
| Zebrafish | 2 | 2017 | 2994 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 2866 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2017 | 6622 | 0.080 |
Why?
|
| Aniline Compounds | 2 | 2022 | 986 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2017 | 4217 | 0.060 |
Why?
|
| Mutation | 4 | 2024 | 29786 | 0.060 |
Why?
|
| DNA | 1 | 2019 | 7301 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4462 | 0.060 |
Why?
|
| Gene Expression | 1 | 2017 | 7799 | 0.060 |
Why?
|
| Models, Biological | 1 | 2020 | 9583 | 0.060 |
Why?
|
| Animals | 7 | 2022 | 168757 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5221 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2021 | 4011 | 0.050 |
Why?
|
| Guatemala | 1 | 2022 | 142 | 0.050 |
Why?
|
| Allosteric Site | 1 | 2021 | 103 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2021 | 210 | 0.050 |
Why?
|
| Humans | 12 | 2024 | 744343 | 0.050 |
Why?
|
| Rats | 1 | 2017 | 24260 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 13102 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 571 | 0.050 |
Why?
|
| Allosteric Regulation | 1 | 2021 | 408 | 0.050 |
Why?
|
| Acrylamides | 1 | 2021 | 255 | 0.040 |
Why?
|
| Chickens | 1 | 2022 | 865 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 68 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2024 | 635 | 0.040 |
Why?
|
| Molting | 1 | 2018 | 10 | 0.040 |
Why?
|
| Sequence Homology | 1 | 2018 | 203 | 0.040 |
Why?
|
| K562 Cells | 1 | 2020 | 634 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2019 | 258 | 0.040 |
Why?
|
| Disulfides | 1 | 2020 | 457 | 0.040 |
Why?
|
| Dogs | 1 | 2022 | 3912 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2023 | 1526 | 0.030 |
Why?
|
| Blood | 1 | 2018 | 598 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2025 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 976 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2021 | 3701 | 0.030 |
Why?
|
| Species Specificity | 1 | 2019 | 2478 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2020 | 970 | 0.030 |
Why?
|
| Mice | 2 | 2018 | 81183 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2024 | 2849 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2023 | 3748 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2187 | 0.030 |
Why?
|
| Cattle | 1 | 2018 | 3922 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2020 | 2455 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2018 | 2132 | 0.020 |
Why?
|
| Rural Population | 1 | 2019 | 2210 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 6171 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2564 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5456 | 0.020 |
Why?
|
| Logistic Models | 1 | 2022 | 13408 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2024 | 12208 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2022 | 23338 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13695 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40075 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 72290 | 0.010 |
Why?
|
| Male | 1 | 2019 | 350118 | 0.000 |
Why?
|
| Female | 1 | 2019 | 380194 | 0.000 |
Why?
|